| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And CEO
1 company
Coats Lonnel is a Chief Executive Officer at LEXICON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 46 buys and 0 sells.
Estimated insider holdings value: $2.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 90,000 | $1.05 | $94,797.00 | +10.9% | +213.2% | -8.0% | |
| Nov 10, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 10,000 | $1.01 | $10,100.00 | +1.2% | +127.7% | +25.7% | |
| Jun 29, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 10,000 | $2.16 | $21,600.00 | +1.2% | -44.2% | -22.6% | |
| Jun 26, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 20,000 | $2.34 | $46,742.00 | +1.3% | -51.2% | -21.7% | |
| Jun 22, 2023 | LXRX Lexicon Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 40,000 | $2.31 | $92,400.00 | +5.4% | -50.0% | -20.3% | |
| Sep 18, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | President And CEO | Buy | 50,000 | $3.10 | $155,000.00 | +28.2% | - | - | |
| Sep 17, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | President And CEO | Buy | 50,000 | $3.13 | $156,403.06 | +7.6% | - | - | |
| Aug 19, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | President And CEO | Buy | 40,000 | $1.35 | $54,028.72 | +4.9% | - | - | |
| Nov 15, 2017 | LXRX Lexicon Pharmaceuticals, Inc. | President And CEO | Buy | 10,000 | $9.91 | $99,100.00 | +30.3% | - | - | |
| Sep 15, 2017 | LXRX Lexicon Pharmaceuticals, Inc. | President And CEO | Buy | 30,000 | $12.54 | $376,336.70 | +5.2% | - | - |